% Generated by roxygen2: do not edit by hand
% Please edit documentation in R/BayesDecisionProbContinuous.R
\name{BayesDecisionProbContinuous}
\alias{BayesDecisionProbContinuous}
\title{Calculate the Go, NoGo and Gray Probabilities for a Clinical Trial When Outcome is Continuous
Under the Bayesian Framework Using Two Metrics}
\usage{
BayesDecisionProbContinuous(
  nsim,
  prob,
  design,
  prior,
  CalcMethod,
  theta.TV,
  theta.MAV,
  theta.NULL,
  nMC = NULL,
  nMCMCsample = NULL,
  gamma1,
  gamma2,
  n1,
  n2,
  m1,
  m2,
  kappa01,
  kappa02,
  nu01,
  nu02,
  mu01,
  mu02,
  sigma01,
  sigma02,
  mu1,
  mu2,
  sigma1,
  sigma2,
  r = NULL,
  ne1 = NULL,
  ne2 = NULL,
  alpha01 = NULL,
  alpha02 = NULL,
  seed
)
}
\arguments{
\item{nsim}{A positive integer representing the number of simulations.}

\item{prob}{A character string specifying the type of probability to calculate
('posterior' or 'predictive').}

\item{design}{A character string specifying the type of trial design
('controlled', 'uncontrolled', or 'external').}

\item{prior}{A character string specifying the prior distribution
('N-Inv-Chisq' or 'vague').}

\item{CalcMethod}{A character string specifying the calculation method
('NI' for numerical integration, 'MC' for Monte Carlo method,
'WS' for Welch-Satterthwaite approximation, or 'MCMC' for MCMC).}

\item{theta.TV}{A numeric value representing the target value threshold.}

\item{theta.MAV}{A numeric value representing the minimum acceptable value threshold.}

\item{theta.NULL}{A numeric value representing the null hypothesis value (default: NULL).}

\item{nMC}{A positive integer representing the number of iterations for Monte Carlo simulation
(required only if CalcMethod = 'MC').}

\item{nMCMCsample}{A positive integer representing the number of iterations for MCMC sampling
(required only if CalcMethod = 'MCMC').}

\item{gamma1}{A numeric value representing the go threshold.}

\item{gamma2}{A numeric value representing the no-go threshold.}

\item{n1}{A positive integer representing the number of patients in group 1.}

\item{n2}{A positive integer representing the number of patients in group 2.}

\item{m1}{A positive integer representing the number of patients in group 1 for future trial.}

\item{m2}{A positive integer representing the number of patients in group 2 for future trial.}

\item{kappa01}{A positive numeric value representing the prior sample size for group 1 (N-Inv-Chisq prior).}

\item{kappa02}{A positive numeric value representing the prior sample size for group 2 (N-Inv-Chisq prior).}

\item{nu01}{A positive numeric value representing the prior degrees of freedom for group 1 (N-Inv-Chisq prior).}

\item{nu02}{A positive numeric value representing the prior degrees of freedom for group 2 (N-Inv-Chisq prior).}

\item{mu01}{A numeric value representing the prior mean for group 1 (N-Inv-Chisq prior).}

\item{mu02}{A numeric value representing the prior mean for group 2 (N-Inv-Chisq prior).}

\item{sigma01}{A positive numeric value representing the prior standard deviation for group 1 (N-Inv-Chisq prior).}

\item{sigma02}{A positive numeric value representing the prior standard deviation for group 2 (N-Inv-Chisq prior).}

\item{mu1}{A numeric value representing the true mean of group 1.}

\item{mu2}{A numeric value representing the true mean of group 2.}

\item{sigma1}{A positive numeric value representing the true standard deviation of group 1.}

\item{sigma2}{A positive numeric value representing the true standard deviation of group 2.}

\item{r}{A positive numeric value for uncontrolled design (default: NULL).}

\item{ne1}{A positive integer representing the sample size for group 1 in external trial (default: NULL).}

\item{ne2}{A positive integer representing the sample size for group 2 in external trial (default: NULL).}

\item{alpha01}{A positive numeric value representing the scale parameter of the power prior for group 1
(required for external design, can be NULL if no external treatment data).}

\item{alpha02}{A positive numeric value representing the scale parameter of the power prior for group 2
(required for external design, can be NULL if no external control data).}

\item{seed}{A numeric value representing the seed number for reproducible random number generation.}
}
\value{
A data frame containing the true means for both groups, and the Go, NoGo, and Gray probabilities.
}
\description{
This function calculates Go, NoGo, and Gray probabilities for continuous outcome clinical trials
under the Bayesian framework using two metrics: (i) posterior probability for the treatment
effect to be greater than a threshold, and (ii) posterior predictive probability of phase III
study success. The function supports controlled, uncontrolled, and external control designs with
multiple calculation methods.
}
\details{
The function can obtain:
\itemize{
\item Go probability
\item NoGo probability
\item Gray probability
}

The function can be used for controlled design, uncontrolled design, and external control design.
The decision framework is based on:
\itemize{
\item Go: Probability that the treatment effect exceeds the efficacy threshold
\item NoGo: Probability that the treatment effect is below the futility threshold
\item Gray: Intermediate zone where neither Go nor NoGo criteria are met
}

The function uses simulation to generate observed data and then applies Bayesian methods to calculate
decision probabilities. Four calculation methods are available for computing the underlying probabilities:
numerical integration (NI), Monte Carlo simulation (MC), Welch-Satterthwaite approximation (WS),
and MCMC for external data incorporation.
}
\examples{
# Example 1: Numerical Integration (NI) method
BayesDecisionProbContinuous(
  nsim = 100, prob = 'posterior', design = 'controlled',
  prior = 'N-Inv-Chisq', CalcMethod = 'NI',
  theta.TV = 2, theta.MAV = 0, theta.NULL = NULL,
  nMC = NULL, nMCMCsample = NULL,
  gamma1 = 0.8, gamma2 = 0.3,
  n1 = 12, n2 = 12, m1 = NULL, m2 = NULL,
  kappa01 = 5, kappa02 = 5, nu01 = 5, nu02 = 5,
  mu01 = 5, mu02 = 5, sigma01 = sqrt(5), sigma02 = sqrt(5),
  mu1 = 4, mu2 = 0, sigma1 = 1, sigma2 = 1,
  r = NULL, ne1 = NULL, ne2 = NULL,
  alpha01 = NULL, alpha02 = NULL, seed = 1
)

# Example 2: Monte Carlo (MC) method
BayesDecisionProbContinuous(
  nsim = 100, prob = 'posterior', design = 'controlled',
  prior = 'vague', CalcMethod = 'MC',
  theta.TV = 1.5, theta.MAV = -1, theta.NULL = NULL,
  nMC = 1e+4, nMCMCsample = NULL,
  gamma1 = 0.8, gamma2 = 0.2,
  n1 = 12, n2 = 12, m1 = NULL, m2 = NULL,
  kappa01 = NULL, kappa02 = NULL, nu01 = NULL, nu02 = NULL,
  mu01 = NULL, mu02 = NULL, sigma01 = NULL, sigma02 = NULL,
  mu1 = 2, mu2 = 0, sigma1 = 1, sigma2 = 1,
  r = NULL, ne1 = NULL, ne2 = NULL,
  alpha01 = NULL, alpha02 = NULL, seed = 2
)

# Example 3: Welch-Satterthwaite (WS) method
BayesDecisionProbContinuous(
  nsim = 100, prob = 'predictive', design = 'controlled',
  prior = 'vague', CalcMethod = 'WS',
  theta.TV = NULL, theta.MAV = NULL, theta.NULL = 1,
  nMC = NULL, nMCMCsample = NULL,
  gamma1 = 0.8, gamma2 = 0.2,
  n1 = 12, n2 = 12, m1 = 24, m2 = 24,
  kappa01 = NULL, kappa02 = NULL, nu01 = NULL, nu02 = NULL,
  mu01 = NULL, mu02 = NULL, sigma01 = NULL, sigma02 = NULL,
  mu1 = 2.5, mu2 = 1.2, sigma1 = 1, sigma2 = 1,
  r = NULL, ne1 = NULL, ne2 = NULL,
  alpha01 = NULL, alpha02 = NULL, seed = 3
)

\dontrun{
# Example 4: MCMC method with external control data
BayesDecisionProbContinuous(
  nsim = 100, prob = 'posterior', design = 'external',
  prior = 'vague', CalcMethod = 'MCMC',
  theta.TV = 1, theta.MAV = -1, theta.NULL = NULL,
  nMC = NULL, nMCMCsample = 3000,
  gamma1 = 0.8, gamma2 = 0.2,
  n1 = 12, n2 = 12, m1 = NULL, m2 = NULL,
  kappa01 = NULL, kappa02 = NULL, nu01 = NULL, nu02 = NULL,
  mu01 = NULL, mu02 = NULL, sigma01 = NULL, sigma02 = NULL,
  mu1 = 2, mu2 = 0, sigma1 = 1, sigma2 = 1,
  r = NULL, ne1 = NULL, ne2 = 20,
  alpha01 = NULL, alpha02 = 0.5, seed = 4
)
}

}
